Aug 22, 2017 articles BenevolentAI poaches drug discovery executive from GlaxoSmithKline FierceBiotech covers the news that we have hired Dr Ian Churcher MA, DPhil as VP of Drug Discovery and Preclinical development. Ian joins from GSK where he previously headed up a Discovery Performance Unit. DRUG DISCOVERY , ARTIFICIAL INTELLIGENCE , RECRUITMENT
Aug 11, 2017 articles AI Hunts for New ALS Treatments Our recent work with the Sheffield Institute of Translational Neuroscience (SITraN) on finding treatments for ALS is featured on Reuters UK. BenevolentBio CEO Professor Jackie Hunter and Dr Richard Mead of SITraN are interviewed about the effects of the disease and the process involved in finding the treatments. ARTIFICIAL INTELLIGENCE , MOTOR NEURONE DISEASE
Aug 9, 2017 articles UK startup BenevolentAI is embarking on major expansion in the US, opening a New York office Lynsey Barber reports on BenevolentAI office opening in New York ARTIFICIAL INTELLIGENCE , BENEVOLENTAI , RECRUITMENT , NEW YORK
Jul 28, 2017 articles Unearthing Tomorrow's Medicine Professor Jackie Hunter speaks to the Science Disrupt podcast about the potential to improve the drug discovery process with machine learning, as well as how AI is streamlining science more generally. In addition to opening up the potential for a whole new universe of potential findings, the podcast covers what this means for science as an evidence-based endeavour and whether it can help to reduce publication bias. ARTIFICIAL INTELLIGENCE , MACHINE LEARNING , HEALTHCARE , JACKIE HUNTER
